JK Tyre & Indust Q1 FY27 Earnings Call — Analysis (NSE: JKTYRE)
JK Tyre Q1FY27 demand was robust with 25% domestic volume growth, but a ~20% sequential raw material spike crushed margins to 6.8%, with management targeting a 2H recovery to 11-13% EBITDA on the back of 8-9% further price hikes.
Result quality: poor — Revenue declined. Management sentiment: cautious.
The take
Q1FY27 Consolidated Revenue ₹3,956 Cr ( +2% YoY ) .
Results
Consolidated revenue ₹3,956 Cr +2% YoY; EBITDA ₹268 Cr -37% YoY; margin 6.8% (-410 bps YoY); PAT ₹43 Cr (-71% YoY) on a ~20% QoQ RM cost increase.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Consolidated Revenue | ₹3,956 Cr | +2% | yoy · Q1FY27 · vs ₹3,891 Cr in Q1FY26 |
| Consolidated EBITDA | ₹268 Cr | -37% | yoy · Q1FY27 · vs ₹424 Cr in Q1FY26 |
| Consolidated EBITDA Margin | 6.8% | -410 bps | yoy · Q1FY27 · vs 10.9% in Q1FY26 |
| Profit After Tax (PAT) | ₹43 Cr | −approx -72% | yoy · Q1FY27 · vs implied profit of ~₹150 Cr in Q1FY26 |
| Average Raw Material Cost | +~20% | qoq · Q1FY27 · vs Q4FY26 | |
| Cash Profit | ₹169 Cr | -45% | yoy · Q1FY27 · vs ₹309 Cr in Q1FY26 |
| Consolidated EPS | ₹1.55 | -74% | yoy · Q1FY27 · vs ₹6.03 in Q1FY26 |
| Consolidated Net Debt | ₹4,945 Cr | +₹500 Cr | qoq · Q1FY27 · as on 30-Jun-2026 vs 31-Mar-2026 |
| Net Debt to Equity | 0.81x | point_in_time · Q1FY27 · as on 30-Jun-2026; vs 0.73x on 31-Mar-2026 | |
| Net Debt to EBITDA | 2.56x | point_in_time · Q1FY27 · as on 30-Jun-2026; vs 2.13x on 31-Mar-2026 |
Guidance
Management expects progressive margin improvement from H2FY27, targeting 11-13% EBITDA margins, double-digit revenue growth, and guided towards ~10-11% full-year consolidated EBITDA margins.
Key themes
Margin recovery play amid commodity headwinds
Operational commentary
- India domestic volumes grew 25% YoY, led by OEM (+42% YoY); TBR replacement +15%, farm OEM +35%.
- Replacement market price hikes: +5% effective in Q1, cumulative +11% till call date; further 8-9% planned, targeting to offset entire RM cost increase except 1-2%.
- Installed capacities in India fully utilized across TBR, PCR, 2/3W segments; consolidated utilization ~80%.
- JK Tornel (Mexico) operations disrupted by geopolitical supply chain issues and a worker slowdown (resolved); production normalizing, better performance expected in remaining three quarters.
- Capacity expansion worth ₹4,980 Cr announced for PCR and TBR at Chennai; ~7% of total existing capacity to be added by next financial year, primarily TBR and PCR balancing at Banmore.
- PCR mix improvement: 16-inch and above high rim-size tyres now 35% of total PCR sales volumes.
- EV tyre portfolio growing double-digit QoQ; EV tyres wear ~5-10% faster than ICE tyres due to higher torque, implying shorter replacement cycle.
- Mobility business (Truck Wheels, Pitstops) growing high double-digits, PAN India ecosystem with 100+ truck wheels and 700+ pitstops.
Analyst Q&A
Q. Clarification on the divergence between 25% domestic volume growth and 14% India revenue growth, and implied pricing.
Management confirmed 25% domestic volume growth YoY and explained that effective price increase in Q1 was ~4% on standalone; NSR increased ~5% QoQ. OEM price hikes lag and will flow through in subsequent quarters.
Q. Details on the nature of supply chain issues affecting JK Tornel in Mexico.
Dr. Bajoria attributed the disruption to shipping constraints, container unavailability, bead wire sourcing from China, and a spike in natural rubber prices (~18% increase). A worker slowdown (not a strike) also impacted output, now resolved. Normal production has resumed.
Q. Quantification of full-year revenue growth and EBITDA margin guidance for FY27.
CFO Sanjeev Aggarwal indicated good double-digit revenue growth (~10-11%) and full-year consolidated EBITDA margins around 10-11%, subject to RM prices; H2 margin expected in 11-13% range.
Q. Update on the status of the USMCA trade agreement.
Dr. Bajoria stated the USMCA agreement has been renewed for 10 years, and the duty structure is expected to remain favourable for Mexico vis-à-vis other US trade partners.
Research and educational content only. Not investment advice.